Stefani A. Wolff
2021
In 2021, Stefani A. Wolff earned a total compensation of $7.1M as Chief Operating Officer and Executive Vice President, Product Development at Nurix Therapeutics.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $67,766 |
| Option Awards | $6,761,172 |
| Salary | $164,576 |
| Other | $4,910 |
| Total | $7,148,424 |
Wolff received $6.8M in option awards, accounting for 95% of the total pay in 2021.
Wolff also received $150K in bonus, $67.8K in non-equity incentive plan, $164.6K in salary and $4.9K in other compensation.
Rankings
In 2021, Stefani A. Wolff's compensation ranked 1,695th out of 12,406 executives tracked by ExecPay. In other words, Wolff earned more than 86.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,695 out of 12,406 | 86th |
Division Manufacturing | 623 out of 5,494 | 89th |
Major group Chemicals And Allied Products | 228 out of 2,369 | 90th |
Industry group Drugs | 191 out of 2,090 | 91st |
Industry Pharmaceutical Preparations | 128 out of 1,537 | 92nd |
Source: SEC filing on March 25, 2022.
Wolff's colleagues
We found four more compensation records of executives who worked with Stefani A. Wolff at Nurix Therapeutics in 2021.